CLINICAL ROLE -
HOPA Provides Plan to Address Oncology Drug Shortages
Experts discuss insight from a recently published oncology drug shortages research project and HOPA’s plan to address related issues based on the project’s findings.
Watch
Mitigate Risk for Errors Involving Paxlovid
Take steps to safeguard prescribing, dispensing, and patient use of the COVID-19 antiviral medication.
Read More
Co-Infected HIV, Hepatitis C Patients May Have Increased Risk of Heart Attack
Research suggests that an HIV patient’s risk of heart attack increases with each passing decade, and this risk is nearly 3-fold among patients with HIV who are also positive for hepatitis C.
OTC Products: September 2022
This month's OTC product news features Hiccupops, deep relief acne treatment, and lidocaine patches.
Pfizer, BioNTech Submit Application for EUA of Omicron Bivalent Booster in Children Aged 5 Through 11
Pfizer and BioNTech have also initiated a phase 1/2/3 study evaluating the safety, tolerability, and immunogenicity of different doses and dosing regimens with the vaccine in children.
The Value of Pursuing BCOP Certification Right After PGY2 Residency Completion
Expert explains how delaying BCOP certification too long after a PGY2 residency can cause a “if you don’t use it, you’ll lose it” problem.
Study Suggests Moral Values Predict Regional Differences in COVID-19 Vaccination Rates
The data showed moral concerns about fairness, loyalty, and purity influenced county-level vaccination rates, but care and authority did not.
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).
Listen
Culturally Competent Care is a Large Part of Pharmacy Care, Deepening Community Connections
Students from the Daniel K. Inouye College of Pharmacy at the University of Hawaii discuss the importance of culturally competent care in Hawaii.
New Analyses Strengthen Efficacy, Safety of Zuranolone for Depression
The research further supports zuranolone as a potential episodic treatment for people with MDD, according to the study authors.
Study: Out-of-State Telemedicine Visits Were Common During the COVID-19 Pandemic
Certain states are proposing that out-of-state telemedicine care should be more accessible, which researchers believe is a trend that will continue.
FDA Approves T-Cell Select Test for Automated Tuberculosis Testing
A new cell isolation kit was approved by the FDA to decrease the amount of time needed in a lab and lower overall costs for testing tuberculosis.
Study Results Show Link Between Excess Weight and Risk of COVID-19, Lasting Disease
Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.
AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging Population
The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.
Supporting Medication Adherence With Motivational Interviewing
Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric Drug
Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Enhancing Patient Engagement With Data, Insights and Digital Tools While Reducing Pharmacy Costs and Improving Outcomes
Specialty pharmacies need processes, systems and tools to quickly determine medication delivery status, reassure confidence, and alleviate patient anxiety.
Pet Peeves: September 2022
Brought to you by The Sassy Pharmacist
Pharmacist Moms’ Dialogues Event Features Vaccination Updates, Addresses Hesitancy
Presentation by Chapman University dean highlights patient relations, staffing issues.
New Modeling System May Advance Care for Autosomal Recessive Polycystic Kidney Disease
Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.
FreeStyle Libre System Reduces Diabetes-Related Hospitalizations for Patients with Type 2 Diabetes
The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.
2022-2023 Influenza Season Looks to Be Severe
Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Study: Children With Primary Immunodeficiency Disease May Have Higher Mortality from COVID-19
In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.
Acupuncture May Reduce Anxiety in Patients With Parkinson’s Disease
Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.
CDC Awards Funding to Assist in Improvement of HIV Testing, Awareness
Program will start to distribute a free HIV self-test to people who enroll by early 2023.
Moonshot 2.0 Looks to Focus on Caregivers, Learn From Patients
Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.
Type 2 Diabetes Treatment Semaglutide May Also Treat Obesity
Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.
Xanomeline-Trospium Could Significantly Decrease Psychosis Symptoms of Schizophrenia in Adults
Following the success of the phase 3 EMERGENT-2 trial, researchers suggest that xanomeline-trospium could be a safe and effective treatment option for adults with schizophrenia.
FDA Grants Priority Review to Tucatinib With Trastuzumab to Treat HER2 Colorectal Cancer
The FDA accepted a supplemental New Drug Application for tucatinib to treat HER2 colorectal cancer, which could significantly improve outcomes for these patients.
NIH Explores New Field of Liberation Data Science in All of Us Research Program
The All of Us Research Program looks to enroll more than 1 million US individuals in the next 10 years to enable public access to medical data for research purposes.